These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34956212)

  • 1. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
    Wang H; Zhang Z; Zhou J; Han S; Kang Z; Chuang H; Fan H; Zhao H; Wang L; Ning Y; Sarapultsev A; Li WX; Li J; Lin Z; Luo S; Xiong N; Hu D
    Front Immunol; 2021; 12():782731. PubMed ID: 34956212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
    Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
    Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B;
    J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation.
    Reinhold D; Farztdinov V; Yan Y; Meisel C; Sadlowski H; Kühn J; Perschel FH; Endres M; Düzel E; Vielhaber S; Guttek K; Goihl A; Venø M; Teegen B; Stöcker W; Stubbemann P; Kurth F; Sander LE; Ralser M; Otto C; Streit S; Jarius S; Ruprecht K; Radbruch H; Kjems J; Mülleder M; Heppner F; Körtvelyessy P
    J Neuroinflammation; 2023 Feb; 20(1):30. PubMed ID: 36759861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.
    Guilmot A; Maldonado Slootjes S; Sellimi A; Bronchain M; Hanseeuw B; Belkhir L; Yombi JC; De Greef J; Pothen L; Yildiz H; Duprez T; Fillée C; Anantharajah A; Capes A; Hantson P; Jacquerye P; Raymackers JM; London F; El Sankari S; Ivanoiu A; Maggi P; van Pesch V
    J Neurol; 2021 Mar; 268(3):751-757. PubMed ID: 32734353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection.
    Schweitzer F; Goereci Y; Franke C; Silling S; Bösl F; Maier F; Heger E; Deiman B; Prüss H; Onur OA; Klein F; Fink GR; Di Cristanziano V; Warnke C
    Ann Neurol; 2022 Jan; 91(1):150-157. PubMed ID: 34724243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral pathogens.
    Neu F; Nay S; Schuchardt S; Klawonn F; Skripuletz T; Suehs KW; Pessler F
    J Transl Med; 2024 Jul; 22(1):620. PubMed ID: 38961383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
    Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
    J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SARS-CoV-2 Detection in cerebrospinal fluid in a pediatric patient. Case report].
    Franco P; Bellesi Y; Nocent E; Strappa A; Galeano ML;
    Arch Argent Pediatr; 2021 Feb; 119(1):e58-e60. PubMed ID: 33458993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in the Diagnosis of SARS-CoV-2 Infection in the Nervous System.
    Da Silva SJ; Cabral-Castro MJ; Gonçalves CCA; Mariani D; Ferreira O; Tanuri A; Puccioni-Sohler M
    Viruses; 2024 Aug; 16(8):. PubMed ID: 39205221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
    Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
    Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms.
    Neumann B; Schmidbauer ML; Dimitriadis K; Otto S; Knier B; Niesen WD; Hosp JA; Günther A; Lindemann S; Nagy G; Steinberg T; Linker RA; Hemmer B; Bösel J;
    J Neurol Sci; 2020 Nov; 418():117090. PubMed ID: 32805440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid in COVID-19: A systematic review of the literature.
    Lewis A; Frontera J; Placantonakis DG; Lighter J; Galetta S; Balcer L; Melmed KR
    J Neurol Sci; 2021 Feb; 421():117316. PubMed ID: 33561753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between CNS Tuberculosis and the COVID-19 Pandemic: The Neurological and Therapeutic Insights.
    Mandal N; De N; Jana P; Sannigrahi A; Chattopadhyay K
    ACS Chem Neurosci; 2020 Sep; 11(18):2789-2792. PubMed ID: 32880441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients.
    Normandin E; Holroyd KB; Collens SI; Shaw BM; Siddle KJ; Adams G; Rudy M; Solomon IH; Anahtar MN; Lemieux JE; Trombetta BA; Kivisakk P; Arnold SE; Rapalino O; Piantadosi AL; Sen P; Rosenberg ES; Branda J; Sabeti PC; Mukerji SS
    J Neurol Sci; 2021 Nov; 430():120023. PubMed ID: 34678659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
    Heming M; Li X; Räuber S; Mausberg AK; Börsch AL; Hartlehnert M; Singhal A; Lu IN; Fleischer M; Szepanowski F; Witzke O; Brenner T; Dittmer U; Yosef N; Kleinschnitz C; Wiendl H; Stettner M; Meyer Zu Hörste G
    Immunity; 2021 Jan; 54(1):164-175.e6. PubMed ID: 33382973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.
    Glavin D; Kelly D; Wood GK; McCausland BM; Ellul MA; Varatharaj A; Galea I; Thomas RH; Michael BD; Gallen B;
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105915. PubMed ID: 34217071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid metabolomic and proteomic characterization of neurologic post-acute sequelae of SARS-CoV-2 infection.
    Chen S; Liang J; Chen D; Huang Q; Sun K; Zhong Y; Lin B; Kong J; Sun J; Gong C; Wang J; Gao Y; Zhang Q; Sun H
    Brain Behav Immun; 2024 Jan; 115():209-222. PubMed ID: 37858739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease.
    Domingues RB; Mendes-Correa MC; de Moura Leite FBV; Sabino EC; Salarini DZ; Claro I; Santos DW; de Jesus JG; Ferreira NE; Romano CM; Soares CAS
    J Neurol; 2020 Nov; 267(11):3154-3156. PubMed ID: 32564153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.